The history of neuropeptides III

Frontiers in Neuroendocrinology

Volumn 17, Issue 2, 1996, Pages 155-179

  Klavdieva, Maria M ^a  

^a RUSSIAN ACADEMY OF SCIENCES   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPEPTIDE; OPIATE RECEPTOR; TACHYKININ;

ANIMAL; ARTICLE; HISTORY; HUMAN; PHYSIOLOGY;

ANIMALS; HISTORY, 20TH CENTURY; HUMANS; NEUROPEPTIDES; RECEPTORS, OPIOID; TACHYKININS;

EID: 0030119596     PISSN: 00913022     EISSN: None     Source Type: Journal    
DOI: 10.1006/frne.1996.0004     Document Type: Article

References (169)

1. Anastasi A, Bertaccini G, Erspamer V. Pharmacological data on phyllokinin (bradykinyl-isoleucyl-tyrosine-O-sulphate) and bradykinyl-isoleucyl-tyrosine. Brit J Pharmacol 1966; 27: 479-485.
2. Anastasi A, Erspamer V, Bucci M. Isolation and structure of Bombesin and alytesin, two analogous active peptides from the skin of the European amphibians Bombina and Alytes. Experientia 1971; 27: 166-167.
3. Anastasi A, Erspamer V, Endean R. Isolation and structure of caerulein, an active decapeptide from the skin of Hyla caerulea. Experientia 1967; 23: 699-700.
4. Anastasi A, Falconieri G, Erspamer V. Occurrence of phyllomedusin, a physalaemin-like decapeptide in the skin of Phyllomedusa bicolor. Experientia 1970; 26: 866-867.
5. Anderson JC, Barton MA, Gregory RA, Hardy PM, Kenner GW, Macleod JK, Preston J, Sheppard RC, Morley JS. Synthesis of gastrin. Nature 1964; 204: 933-934.
6. Applezweig MH, Baudry FD. The pituitary-adrenocortical system in avoidance learning. Psychol Rep 11955; 1: 417-420.
7. Applezweig MH, Moeller G. The pituitary-adrenocortical system and anxiety in avoidance learning. Acta Psychol 1959; 15: 602-603.
8. Araki K, Tachibana S, Uchiyama M, Nakajima T, Yusuhara T. Isolation and structure of a new active peptide "xenopsin" on the smooth muscle, especially on a stripe of fundus from a rat stomach, from the skin of Xenopus laevis. Chem Pharm Bull 1973; 21: 2801-2804.
9. Aurbach GD, Potts JT. Partition of parathyroid hormone on Sephadex G-100. Endocrinology 1964; 75: 290-292.
10. Baghdiantz A, Foster GY, Edwards A, Kumar MA, Slack E, Soliman HA, MacIntyre I. Extraction and purification of calcitonin. Nature 1964; 203: 1027-1028.
11. Beckett AH, Casy AF. Synthetic analgesics: Stereochemical considerations. J Pharm Pharmacol 1954; 6: 986-1001.
12. Belanger D. Effets de l'hypophysectomie sur l'apprentissage d'uneréaction échappement -évitement. Can J Physiol 1958; 12: 171-178.
13. Bell PH, Barg WF, Colucci DF, Davies MC, Dziobkowski C, Englert ME, Heyder E, Paul R, Snedeker EH. Purification and structure of porcine calcitonin-1. J Am Chem Soc 1968; 90: 2704-2706.
14. Benfey BJ, Purvis JL. Purification and amino acid composition of melanophore-expanding hormone from hog pituitary gland. J Am Chem Soc 1955; 77: 5167-5168.
15. Bergland R, Blume H, Hamilton A, Monica P, Paterson R. Adrenocorticotropic hormone may be transported directly from the pituitary to the brain. Science 1980; 210: 541-543.
16. Bernardi L, Bosisio G, De Castiglione R, Goffredo O. Synthesis of caerulein. Experientia 1967; 23: 700-702.
17. Bernardi R, Bosisio G, Goffredo O, De Castiglione R. Synthesis of physalaemin. Experientia 1964; 20: 490-492.
18. Bickerton RK, Buckley JP. Evidence for a central mechanism in angiotensin induced hypertension. Proc Soc Exp Biol Med 1961; 106: 834-836.
19. Blobel G, Dobberstein D. Transfer of proteins across membranes. 1. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma. And 2. Reconstitution of functional rough microsomes from heterologous components. J Cell Biol 1975; 67: 835-851; 852-862.
20. Blobel G, Sabatini DD. Ribosome-membrane interaction on eucaryotic cells. In: Manson LA, Ed. Biomembranes. Vol. 2. New York: Plenum, 1971: 193-195.
21. Bodanszky M, Klausner JS, Said SI. Biological activities of synthetic peptides corresponding to fragments and to entire sequence of the vasoactive intestinal peptide. Proc Natl Acad Sci USA 1973; 70: 382-384.
22. Bodanszky M, Ondetti MA, Levine SD, Williams NJ. Synthesis of secretin. II. The stepwise approach. J Am Chem Soc 1967; 89: 6753-6757.
23. Bohus B, de Wied D. Inhibitory and facilitatory effect of two related peptides on extinction of avoidance behavior. Science 1966; 153: 318-320.
24. Brewer HB, Ronan R. Bovine parathyroid hormone: Amino acid sequence. Proc Natl Acad Sci USA 1970; 67: 1862-1869.
25. Bromer WW, Sinn LG, Behrens OK. The amino acid sequence of glucagon. V. Location of amide groups, acid degradation studies and summary of sequential evidence. J Am Chem Soc 1957; 79: 2807-2810.
26. Brown JC, Cook MA, Dryburgh JR. Motilin, a gastric motor activity stimulating polypeptide: The complete amino acid sequence. Can J Biochem 1973; 51: 533-537.
27. Brown JC, Dryburgh JR. A gastric inhibitory polypeptide. II. The complete amino acid sequence. Can J Biochem 1971; 49: 867-872.
28. Brown JC, Mutt V, Pedersen RA. Further purification of a polypeptide demonstrating enterogastrone activity. J Physiol 1970; 209: 57-64.
29. Buckley JP, Bickerton RK, Halliday RP, Kato H. Central effects of peptides on the cardiovascular system. Ann NY Acad Sci 1963; 104: 299-310.
30. Burbach JPH. Action of proteolytic enzymes on lipotropins and endorphins: Biosynthesis, biotransformation and fate. In: de Wied D, Gispen WH, Van Wimersma Greidanus T, Eds. Int Encyclopedia of Pharmacology and Therapeutics, Section 117, Vol. 1, Neuropeptides and Behavior. Oxford: Pergamon Press, 1986: 43-76.
31. Burbach JP, de Wied D. Memory effects and brain proteolysis of neurohypophyseal hormones. In: Schlesinger D, Ed. Neurohypophyseal peptide hormones and other biologically active peptides. New York: Elsevier 1981: 69-87.
32. Capek R. Some effects of bradykinin on the central nervous system. In: Uvnas B, Ed. Proc Int Pharmacol Meeting. Vol. 9, Part 1, Bradykinin and vaso-dilating polypeptides Oxford/London/ New York/Paris: Pergamon; 1963: 61-64.
33. Chretien M, Li CH. Isolation, purification and characterization of gamma-lipotropic hormone from sheep pituitary glands. Can J Biochem 1967; 45: 1163-1174.
34. Collier HOJ. Pharmacological mechanisms of drug dependence. In: Cochin J, Way EL, Eds. Pharmacology and the Future of Man. Proc 5th Int. Congr. Pharmacol. San-Francisco, 1972. Vol. 1. Basel: Karger; 1973: 65-76.
35. Copp DH, Cameron EC, Cheney BA, Davidson AGF, Henze KG. Evidence for calcitonin - A new hormone from the parathyroid that lowers blood calcium. Endocrinology 1962; 70: 638-649.
36. Daniels AE, Ogden E, Vernikos-Danellis J. Effects of centrally administered angiotensin II in the unanesthetized rats. Physiologist 1969; 12: 205.
37. Davis VE, Walsh HJ. Alcohol, amines and alkaloids: A possible biochemical basis for alcohol addiction. Science 1970; 167: 1005-1007.
38. De Wied D. An assay of corticotropin releasing principles in hypothalamic lesioned rats. Acta Endocrinol 37: 288-297.
39. De Wied D. Effects of peptide hormones on behavior. In: Ganong WF, Martini L, Eds. Frontiers in Neuroendocrinology. New York: Oxford Univ. Press; 1969: 97-140.
40. De Wied D. Hormonen en gedrag. Uit Natuur en Techniek, 39e jaargang, 1971, p. 10.
41. De Wied D. Influence of anterior of anterior pituitary on avoidance learning and escape behavior. Am J Physiol 1964; 207: 255-259.
42. De Wied D. Inhibitory effect of ACTH and related peptides on extinction of conditioned avoidance behavior in rats. Proc Soc Exp Biol Med 1966; 122: 28-32.
43. De Wied D. Neuropeptides and behavior. In: Parnham MJ, Bruinvels J, Eds. Discoveries in Pharmacology, Vol. I, Psycho-and Neuro-pharmacology. Elsevier 1983: 307-353.
44. De Wied D. Pituitary peptides and adaptive behavior. In: Meites J, Donovan B, McCann SM, Eds. Pioneers in Neuroendocrinology II, Vol. 2, Perspectives in Neuroendocrine Research. New York/London: Plenum, 1978: 385-399.
45. De Wied D. The influence of the posterior and intermediate lobe of the pituitary and pituitary peptides on the maintenance of a conditioned avoidance response. Int J Neuropharmacol 1965; 4: 157-167.
46. De Wied D. The significance of the antidiuretic hormone in the release mechanism of corticotropin. Endocrinology 1961; 68: 956-970.
47. De Wied D, Bohus B. Long term and short term effects on retention of a conditioned avoidance response in rats by treatment with long acting pitressin and alpha-MSH. Nature 1966; 212: 1484-1486.
48. De Wied D, Bouman PR, Smelik PG. The effect of the lipid extract from the posterior hypothalamus and of pitressin on the release of ACTH from the pituitary gland. Endocrinology 1958; 62: 605-613.
49. De Wied D, Gispen WH. Behavioral effects of peptides. In: Gainer H, Ed. Peptides in Neurobiology. New York/London: Plenum, 1977: 397-448.
50. De Wied D, Jolles J. Neuropeptides derived from pro-opiocortin: Behavioral, physiological, and neurochemical effects. Physiol Rev 1982; 62: 976-1059.
51. De Wied D, Mirsky IA. The action of delta 1 hydrocortisone on the antidiuretic and adrenocorticotropic responses to noxious stimuli. Endocrinology 1959; 64: 955-966.
52. Eddy NB, May EL. The search for a better analgesic. Science 1973; 181: 407-414.
53. Elliott DF. The discovery and characterization of bradykinin. In: Eichler O, Parah A, Herken H, Welch AD, Eds. Handbuch der experimentellen Pharmakologie, Vol. XXV, Bradykinin, Kalliddin, Kallikrein. Berlin/Heidelberg/New York: Springer-Verlag, 1970: 7-13.
54. Epstein AN, Fitzsimmons JT, Simons BJ. Drinking caused by the injection of angiotensin into the brain of the rat. J Physiol 1969; 200: 98P-100P.
55. Erspamer V. The tachykinin peptide family. Trends Neurosci 1981; 4: 267-269.
56. Erspamer V. Wirksame Stoffe der hinteren Speicheldrusen der Octopoden und der Hypobranchialdrüse der Purpurschnecken. Arzneimittel-Forschung 1952; 2: 253-258.
57. Erspamer V, Anastasi A, Bertaccini G, Cei JM. Structure and pharmacological actions of physalaemin, the main active polypeptide of the skin of Physalaemus fuscumaculatus. Experientia 1964; 20: 489-490.
58. Erspamer V, Anastasi A. Structure and pharmacological actions of eledoisin, the active endecapeptide of the posterior salivary glands of Eledone. Experientia 1962; 18: 58-59.
59. Erspamer V, Bertaccini G, Cei JM. Occurrence of an eledoisin-like polypeptide (physalaemin) in skin extracts of Physalaemus fuscumaculatus. Experientia 1962; 18: 562-563.
60. Erspamer V, Bertaccini G, Cei JM. Occurrence of bradykinin-like substances in the amphybian skin. Experientia 1962; 18: 563-564.
61. Erspamer V, Bertaccini G, De Caro G, Endean R, Impicciatore M. Pharmacological actions of caerulein. Experientia 1967; 23: 702-703.
62. Erspamer V, Roseglini M, Endean R, Anastasi A. Biogenic amines and active polypeptides in the skin of Australian amphibians. Nature 1966; 212: 204.
63. Ettenberg A, Van der Kooy D, Le Moal M, Koob GF, Bloom FE. Can aversive properties of (peripherally injected) vasopressin account for ite putative role in memory? Behav Brain Res 1983; 7: 331-350.
64. Ferrari W. Behavioral effects in animals after intracisternal injection with adrenocorticotropic hormone and melanocyte-stimulating hormone. Nature 1958; 181: 925-926.
65. Ferrari W, Gessa GL, Vargiu L. Behavioral effects induced by intracisternally injected ACTH and MSH. Ann NY Acad Sci 1963; 104: 330-345.
66. Fischer-Ferraro C, Nahmod VE, Goldstein DF, Finkielman S. Angiotensin and renin in rat and dog brain. J Exp Med 1971; 133: 353-361.
67. Fishman L. Purification and structure of secretin. Fed Proc 1959; 18: 226.
68. Fitzsimmons JT. The effect on drinking of peptide precursors and of shorter chain peptide fragments of angiotensin II injected into the rat's diencephalon. J Physiol 1971; 214: 293-303.
69. Ganten D, Minnich JL, Granger P, Hayduk K, Brecht HM, Barbeau A, Boucher R, Genest J. Angiotensin-forming enzyme in brain tissue. Science 1971; 173: 64-65.
70. Geschwind II, Li CH, Barnafi L. Isolation and structure of melanocyte stimulating hormone from porcine piuitary glands. J Am Chem Soc 1956; 78: 4494-4495.
71. Gessa GL, Pisano M, Vargiu L, Crabai F, Ferrari W. Stretching and yawning movements after intracerebral injections of ACTH. Rev Can Biol 1967; 26: 229-236.
72. Goldstein A. Opioid peptides (endorphins) in pituitary and brain. Science 1976; 193: 1081-1085.
73. Goldstein A, Lowney LI, Pal BK. Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain. Proc Natl Acad Sci USA 1971; 68: 1742-1747.
74. Graeff FG, Pela IR. Rocha e Suva M. Behavioral and somatic effects of bradykinin injected into cerebral ventricles of unanaesthetized rabbit. Br J Pharmacol 1969; 37: 723-732.
75. Gregory H, Hardy PM, Jones DS, Kenner GW, Sheppard RC. Structure of gastrin. Nature 1964; 204: 931-933.
76. Greven HM, de Wied D. The influence of peptides derived from corticotropin (ACTH) on performance. Structure activity studies. In: Zimmermann E, Gispen WH, Marks BH, de Wied D, Eds. Drug Effects on Neuroendocrine Regulation, Vol. 39 Progress in Brain Research. Amsterdam: Elsevier, 1973: 429-442.
77. Guzman F, Braun C, Lim RKS. Visceral pain and pseudoaffective response to intraarterial injection of bradykinin and other algesic agents. Arch Int Pharmacodyn Ther 1962; 136: 353-384.
78. Harris JI, Lerner AB. Amino acid sequence of the alpha-melanocyte-stimulating hormone. Nature 1957; 179: 1346-1347.
79. Harris JI, Roos P. Amino acid sequence of a melanophore stimulating hormone. Nature 1956; 178: 90.
80. Hendler NH, Blake WD. Hypothalamic implants of angiotensin II, carbachol, and norepinephrine on water and NaCl solution intake in rats. Commun Behav Biol 1969; 4: 41-48.
81. Hiller JM, Pearson J, Simon EJ. Distribution of stereospecific binding of potent narcotic analgesic etorphine in human brain - Predominance in limbic system. Res Commun Chem Pathol Pharmacol 1973; 6: 1052-1062.
82. Hirsch PF, Gauthier GF, Munson PL. Thyroid hypocalcemic principle and recurrent laryngeal nerve injury as factors affecting the response to parathyroid ectomy in rats. Endocrinology 1963; 73: 244-252.
83. Hirsch PF, Voelkel EF, Munson PL. Thyrocalcitonin: Hypocalcemic hypophosphatemic principle of the thyroid gland. Science 1964; 146: 412-413.
84. Jacob JJ, Tremblay EC, Colombel MC. Facilitation de reactions nociceptives par la naloxone chez le sourit et chez le rat. Psychopharmacologia 1974; 37: 217-223.
85. Jorpes E, Mutt V. On the biological activity and amino acid composition of secretin. Acta Chem Scand 1961; 15: 1790-1791.
86. Jorpes JE, Mutt V, Magnusson S, Steele BB. Amino acid composition and N-terminal amino acid sequence of porcine secretin. Biochem Biophys Res Commun 1962; 9: 275-279.
87. Kastin AJ, Ehrensing RH, Banks WA, Zadina JE. Possible therapeutic implications of the effects of some peptides on the brain. Prog Brain Res 1987; 72: 223-234.
88. Kornmuller AE, Lux HD, Winkel K, Klee M. Neurohumoral ausgeloste Schlafzustande an Tieren mit gekreuztem Kreislauf unter der Kontrolle von EEG-Ableitungen. Naturwissenschaften 1961; 48: 503-505.
89. Krivoy W. The preservation of substance P by lysergic acid diethylamide. Br J Pharmacol 1957; 12: 361-364.
90. Krivoy W, Lane M, Kroeger DC. The action of certain polypeptides on synaptic transmission. Ann NY Acad Sci 1963; 104: 312-329.
91. Krivoy WA, Guillemin R. On a possible role of beta-melanocyte stimulating hormone (beta-MSH) in the central nervous system of mammals: An effect of beta-MSH in the spinal cord of the cat. Endocrinology 1961; 69: 170-175.
92. Lande S, Witter A, de Wied D. Pituitary peptides: An octapeptide that stimulates conditioned avoidance aquisition in hypophysectomized rats. J Biol Chem 1971; 246: 2058-2062.
93. Lee TH, Lerner AB. Isolation of melanocyte-stimulating hormone from hog pituitary gland. J Biol Chem 1956; 221: 943-959.
94. Lerner AB, Lee TH. Isolation of homogenous melanocyte stimulating hormone from hog pituitary gland. J Am Chem Soc 1955; 77: 1066-1067.
95. Levine S, Jones LE. Adrenocorticotropic hormone (ACTH) and passive avoidance learning. J Comp Physiol Psychol 1965; 59: 357-360.
96. Li CH, Barnafi L, Chrétien M, Chung D. Isolation and amino acid sequence of beta-LPH from sheep pituitary glands. Nature 1965; 208: 1093-1094.
97. Li CH, Dixon JS, Liu WK. Human pituitary growth hormone. XIX The primary structure of the hormone. Arch Biochem Biophys 1969; 133: 70-91.
98. Li CH, Dixon JS, Lo TB, Pankov YA, Schmidt KD. Amino-acid sequence of ovine lactogenic hormone. Nature 1969; 224: 695-696.
99. Li CH, Dixon JS. Human pituitary growth hormone. II. Primary structure of hormone -revision. Arch Biochem Biophys 1971; 146: 233-236.
100. Li CH, Liu WK, Dixon JS. Human pituitary growth hormone. XII. The amino acid sequence of the hormone. J Am Chem Soc 1966; 88: 2050-2051.
101. Li CH, Yamashiro DJ. The synthesis of a protein possessing growth-promoting and lactogenic activities. J Am Chem Soc 1970; 92: 7608-7609.
102. Lingappa VR, Blobel G. Early events in the biosynthesis of secretory and membrane proteins: The signal hypothesis. Rec Progr Horm Res 1980; 36: 451-475.
103. Lissak K, Endroczi E. The Neuroendocrine Control of Adaptation. Oxford: Pergamon, 1965.
104. Martin WR. Opioid antagonists. Pharmacol Rev 1967; 19: 463-521.
105. Matsumoto J, Sogabe K, Horisanto Y. Sleep in parabiosis. Experientia 1972; 28: 1043-1044.
106. Mayer DJ, Liebskind JC. Pain reduction by focal electrical stimulation of the brain: An anatomical and behavioral analysis. Brain Res 1974; 68: 73-93.
107. Mayer DJ, Wolfe TL, Akil H, Carder B, Liebskind JC. Analgesia from electrical stimulation in the brainstem of the rat. Science 1971; 174: 1351-1354.
108. Michals EA, Kastin AJ, Banks WA. Carrier-mediated transport of arginine-vasopressin across the blood-brain barrier. Clin Res 1986; 34: 199A.
109. Miller RE, Ogawa N. The effect of adrenocorticotropic hormone (ACTH) on avoidance conditioning in the adrenalectomized rat. J Comp Physiol Psychol 1962; 55: 211-213.
110. Mirsky IA, Miller RE, Stein M. Relation of adrenocortical activity and adaptive behavior. Psychosom Med 1953; 15: 574-588.
111. Monnier M, Hosli I. Dialysis of sleep and waking factors in blood of the rabbit. Science 1964; 146: 796-798.
112. Monnier M, Koller T, Graber S. Humoral influences of induced sleep and arousal upon brain activity of animals with crossed circulation. Exp Neurol 1963; 8: 264-277.
113. Moss RL, McCann SM. Introduction of mating behavior in rats by luteinizing hormone releasing factor. Science 1973; 181: 177-179.
114. Murphy JW, Miller RE. The effect of adrenocorticotropic hormone (ACTH) on avoidance conditioning in the rat. J Comp Physiol Psychol 1955; 48: 47-49.
115. Mutt V, Jorpes E. Hormonal polypeptides of the upper intestine. Biochem J 1971; 125: 57P-58P.
116. Mutt V, Jorpes JE, Magnusson S. Structure of porcine secretin. The amino acid sequence. Eur J Biochem 1970; 15: 513-519.
117. Mutt V, Jorpes JE. Structure of porcine cholecystokinin-pancreozymin. I. Cleavage with trombin and with trypsin. Eur J Biochem 1968; 6: 156-162.
118. Mutt V, Said SI. Structure of the porcine vasoactive intestinal octacosapeptide. The amino-acid sequence. Use of kallikrein in its determination. Eur J Biochem 1974; 42: 581-589.
119. Nakajima T, Tanimura T, Pisano JJ. Isolation and structure of a new vasoactive polypeptide. Fed Proc 1970; 29: 282.
120. Neher R, Riniker B, Kittel W, Zuber H. Menschliches Calcitonin III Struktur von Calcitonin M und D. Helv Chim Acta 1968; 51: 1900-1905.
121. Newton GGF, Love JW, Heatley NG, Abraham EP. Purification of secretin. Biochem J 1969; 71: 6P.
122. Niall HD, Keutmann H, Sauer R, Hogan M, Dawson B, Aurbach G, Potts JT. The amino-acid sequence of bovine parathyroid hormone I. Hoppe-Seyler's Z Physiol Chem 1970; 351: 1586-1588.
123. Palade GE. Intracellular aspects of the process of protein synthesis. Science 1975; 189: 347-350.
124. Pappenheimer JR, Miller TB, Goodrich CA. Sleep-promoting effects of cerebrospinal fluid from sleep-deprived goats. Proc Natl Acad Sci USA 1967; 58: 513-517.
125. Pert CB, Snyder SH. Opiate receptor: Demonstration in nervous tissue. Science 1973; 179: 1011-1014.
126. Pert CB, Snyder SH. Properties of opiate receptor binding in rat brain. Proc Natl Acad Sci USA 1973; 70: 2243-2247.
127. Pfaff DW. Luteinizing hormone-releasing factor potentiates lordosis behavior in hypophysectomized ovariectomized rats. Science 1973; 182: 1148-1149.
128. Pierce JG, Liao T, Howard SM, Shome B, Cornell JS. Studies on the structure of thyrotropin: Its relationship to luteinizing hormone. Rec Progr Horm Res 1971; 27: 165-212.
129. Piper PJ, Said SI, Vane JR. Effects on smooth muscle preparation of unidentified vasoactive peptides from intestine and lung. Nature 1970; 225: 1144-1146.
130. Porath J, Roos P, Landgrebe FW, Mitchell GM. Isolation of a melanophore-stimulating peptide from pig pituitary gland. Biochim Biophys Acta 1955; 17: 598-599.
131. Portoghese PS. A new concept on the mode of interaction of narcotic analgesics with receptors. J Med Chem 1965; 8: 609-616.
132. Potts JT, Niall HD, Keutmann HT, Brewer HB, Deftos LJ. Amino acid sequence of porcine thyrocalcitonin. Proc Natl Acad Sci USA 1968; 59: 1321-1328.
133. Rasmussen H, Craig LC. Purification of parathyroid hormone by use of countercurrent distribution. J Am Chem Soc 1959; 81: 5003.
134. Reynolds DV. Surgery in the rat during electrical analgesia induced by focal brain stimulation. Science 1969; 164: 444-445.
135. Rigter H, Van Riezen H, De Wied D. Effects of ACTH analogs and vasopressin analogs on CO2-induced retrograde amnesia in rats. Physiol Behav 1974; 13: 381-388.
136. Rigopoulou D, Valverde I, Marco J, Faloona G, Unger RH. Large glucagon immunoreactivity in extracts of pancreas. J Biol Chem 1970; 245: 496-501.
137. Rittel W, Iselin B, Kappeler H, Riniker B, von Schwyzer R. Synthese eines hochwirksamen Hypertensin II-amids (L-Asparaginyl-Larginyl-L-Valyl-L-Tyrosyl-L-Isoleucyl-L-Histidyl-L-Prolyl-L -Phenylalanine). Helv Chim Acta 1957; 40: 614-624.
138. Roth J, Gorden P, Pastan I. "Big insulin": A new component of plasma insulin detected by immunoassay. Proc Natl Acad Sci USA 1968; 61: 138-145.
139. Ryzhikov VN. Razvitije napravlenija i etapy v razvitii himii alkaloidov. Diss kand him nauk Moskva, 1979.
140. Sabatini DD, Tashiro Y, Palade GE. On the attachment of ribosomes to microsomal membranes. J Mol Biol 1966; 19: 503-524.
141. Sahgal A, Keith AB, Wright C, Edwardson JA. Failure of vasopressin to enhance memory in a passive avoidance task in rats. Neurosci Lett 1982; 28: 87-92.
142. Said SI, Mutt V. A peptide fraction from lung tissue with prolonged peripheral vasodilator activity. Scand J Clin Lab Invest 1969; 24(Suppl 107): 51-57.
143. Said SI, Mutt V. Isolation from porcine intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon. Eur J Biochem 1972; 28: 199-204.
144. Said SI, Mutt V. Polypeptide with broad biological activity: Isolation from small intestine. Science 1970; 169: 1217-1218.
145. Said SI, Mutt V. Potent peripheral and splanchnic vasodilator peptide from normal gut. Nature 1970; 225: 863-864.
146. Sandman CA, Kastin AJ, Schally AV Melanocyte stimulating hormone and learned appetitive behavior. Experientia 1969; 25: 10012.
147. Sandrin E, Boissonas RA. Synthesis of eledoisin. Experientia 1962; 18: 59-61.
148. Schachter M. Discovery of non-mammalian kinins. In: Eichler O, Parah A, Herken H, Welch AD, Eds. Handbuch der experimentellen Pharmakologie, Vol. XXV, Bradykinin, kalliddin, kallikrein. Berlin/Heidelberg/New York: Springer-Verlag; 1970: 585-588.
149. Scott AP, Ratcliffe JG, Rees LH, Landon J, Bennett HPJ, Lowry PJ, McMartin C. Pituitary peptide. Nature New Biol 1973; 244: 65-67.
150. Severs WB, Daniels-Severs AE. Effect of angiotensin on the central nervous system. Pharmacol Rev 1973; 25: 415-149.
151. 3H]etorphin to rat brain homogenate. Proc Natl Acad Sci USA 1973; 70: 1947-1949.
152. Skopkova J, Croiset G, de Wied D. Differential effects of DGAVP on acquisition and extinction of active avoidance behavior. Peptides 1991; 12: 471-475.
153. Staub A, Linn L, Behrens OK. Purification and crystallization of glucagon. J Biol Chem 1955; 214: 619-632.
154. Steiner DF, Cunningham D, Spigelman L, Atin B. Insulin biosynthesis - Evidence for a precursor. Science 1967; 157: 697-700.
155. Sutherland EW, Oeye I, Butcher RW. The action of epinephrine and the role of the adenyl cyclase system in hormone action. Rec Progr Horm Res 1965; 21: 623-642.
156. Sutherland EW, Robison GA. Role of 3′,5′-AMP in responses to catecholamines and other hormones. Pharmacol Rev 1966; 18: 145-161.
157. Terenius L. Characteristics of the "receptor" for narcotic analgesics in synaptic plasma membrane fractions from rat brain. Acta Pharmacol Toxicol 1973; 33: 377-384.
158. Terenius L. Specific uptake of narcotic analgesics by subcellular fractions on the guinea pig ileum. Acta Pharmacol Toxicol 1972; 31: 50.
159. Torok B. Neue Angaben zum Blutkreislauf der Hypophyse, Verhandlungen des 1. Europaischen Anatomenkongressen. Anat Anz 1960; 109: 622-629.
160. Tracy HJ, Gregory RA. Physiological properties of a series of synthetic peptides structurally related to gastrin I. Nature 1964; 204: 935-938.
161. Ungar G. Role of proteins and peptides in learning and memory. In: C. Ungar, Ed. Molecular Mechanisms, in Memory and Learning. New York/London: Plenum, 1970: 149-175.
162. Von Schwyzer R, Iselin B, Kappeler H, Riniker B, Rittel W, Zuber H. Synthese hochwirksamer Octapeptide mit der vermutlichen Aminosauresequenz des noch unbekannten Hypertensins II aus Rinderserum (Val5-Hypertensin II und Val5-Hypertensin II-Asp-betaamid). Helv Chim Acta 1958; 41: 1287-1295.
163. Walaszek EJ. Effect of bradykinin on the central nervous system. In: Eichler O, Parah A, Herken H, Welch AD, Eds. Handbuch der experimentellen Pharmakologie, Vol. XXV, Bradykinin, kalliddin, kallikrein. Berlin/Heidelberg/New York: Springer-Verlag, 1970: 430-433.
164. Weijlard J, Erickson AE. N-Allylnormorphine. J Am Chem Soc 1942; 64: 869-870.
165. Werle E. Discovery of the most important kallikreins and kallikrein inhibitors. In: Eichler O, Parah A, Herken H, Welch AD, Eds. Handbuch der experimentellen Pharmakologie, Vol. XXV, Bradykinin, kalliddin, kallikrein. Berlin/Heidelberg/New York: Springer-Verlag; 1970: 1-6.
166. Yalow RS. Heterogeneity of peptide hormones. Rec Progr Horm Res 1974; 30: 597-633.
167. Yalow RS. Radioimmunoassay methodology: Application to problems of heterogeneity of peptide hormones. Pharmacol Rev 1973; 251: 161-178.
168. Yalow RS, Berson SA. And now, "big," "big" gastrin. Biochem Biophys Res Commun 1972; 48: 391-395.
169. Yudajev NA, Ed. Biokhimija gormonov i gormonalnoi reguljatsii. Moskva: Nauka, 1976.